ENDOMATERIALS - CHEVALIER
Endomaterials - Chevalier engages in the development and commercialization of medical devices for endovascular applications.
ENDOMATERIALS - CHEVALIER
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2010-01-01
Address:
Neuchâtel, Neuchatel, Switzerland
Country:
Switzerland
Status:
Active
Similar Organizations
Aurora Biofarma
Aurora Biofarma engages in the research, development and marketing of nutraceutical, biological and medical device products.
Heart Sentinel
Heart Sentinel deals with the development of algorithms dedicated to prevention in the cardiology field.
Laboratorios Gebro Pharma
Laboratorios Gebro Pharma is ​​focuses on the development and commercialization of treatments against pain and inflammation.
Neurelec SA
Neurelec SA engages in the development, manufacture, and commercialization of auditory implantable systems.
Polymer Therapeutics LLC
Polymer Therapeutics, LLC has developed biocompatible, bioabsorbable drug-eluting polymers (BDEPâ„¢) for medical device coating applications.
SonoMedix
SonoMedix engages in the development and commercialization of technology designed for monitoring blood coagulation and hemostatic status.
VeinVis
VeinVis is engaged in the development and production of the device for vein visualization.
More informations about "Endomaterials - Chevalier"
Endomaterials - Chevalier - Crunchbase Company Profile & Funding
Organization. Endomaterials - Chevalier . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. ... Endomaterials - Chevalier is located in Neuchâtel, Neuchatel, …See details»
Endomaterials - Chevalier - Drug pipelines, Patents, Clinical trials ...
Mar 18, 2024 Explore Endomaterials - Chevalier with its drug pipeline, therapeutic area, technology platform, .See details»
Endomaterials Chevalier - Overview, News & Competitors
Endomaterials Chevalier - Business Information. Consumer Services · Switzerland · <25 Employees. Endomaterials Chevalier is a company that operates in the Internet industry. It …See details»
Polymer Therapeutics LLC - Crunchbase Company Profile & Funding
Alternatives and possible competitors to Polymer Therapeutics LLC may include 4P Therapeutics, Alera Labs, and Endomaterials - Chevalier. Unlock even more features with Crunchbase Pro …See details»
BioPhotonics - Photonics in Life Sciences 19.03.2014, Muttenz BL
Dr. Eric Chevalier Endomaterials [email protected] Dr. Yann Jérôme Cotte Nanolive SA [email protected] Luc Coupet Andor [email protected] Dr. Marlen …See details»
ENDOMATERIALS CORPORATION | Florida Company Directory
Endomaterials Corporation's dissolution date is Sep 26 2014 and it had been 1 years 1 months, and 7 days since its registered. Document No. P13000069064 ... CHEVALIER, ERIC . P . 407 …See details»
Eric Chevalier email address & phone number | Endomaterials …
Eric Chevalier Email Owner and Managing Director @ Endomaterials Preparing Eric profile… View Eric's Email (It's Free) 5 free lookups per month. No credit card required. Location. Bern, …See details»
Eric Chevalier - Previous President for Endomaterials Corporation
View Eric Chevalier's profile for company associations, background information, and partnerships. Search our database of over 100 million company and executive profiles. ... Endomaterials …See details»
ENDOMATERIALS - CHEVALIER - CHE-442.831.440 - LEI …
⚪ ENDOMATERIALS - CHEVALIER, Cím: rue de la Maladière 71, Neuchâtel, 2000, CH. Nincs kiadott LEI-kód. Utoljára frissítve: 2022. 08. 02. A LEI Magyarország adatbázisa össze van …See details»
ENDOMATERIALS CHEVALIER - Rue de la Maladière 71, Neuchâtel …
Endomaterials Chevalier in Neuchâtel, reviews by real people. Yelp is a fun and easy way to find, recommend and talk about what’s great and not so great in Neuchâtel and beyond.See details»
ENDOMATERIALS - Translation into French - Reverso Context
Translations in context of "ENDOMATERIALS" in English-French from Reverso Context: At present, there is no news for ENDOMATERIALS - CHEVALIER. Translation Context Grammar …See details»
The Potential Role of Graphene in Developing the Next Generation …
Nov 29, 2016 1. Introduction. Material specifications and techniques are critical for the evolution of endovascular surgery. Graphene is a two-dimensional carbon allotrope comprised of sp 2 …See details»
Endodontic materials | PPT - SlideShare
Aug 28, 2014 Endodontic materials are used to obturate and seal root canals after pulp tissue destruction and infection. Common materials include irrigants like sodium hypochlorite and …See details»
Biocompatible Carbon-Based Coating as Potential Endovascular …
Oct 4, 2018 The potential role of graphene in developing the next generation of endomaterials. BioMed Research International. 2016; 2016:7. doi: 10.1155/2016/3180954. 3180954 [PMC …See details»
Endocrowns: Indications, Preparation Techniques, and Material …
Manufacturing. Two methods can be utilized for fabricating endocrowns: heat pressing or CAD/CAM [].In the heat pressing technique, the endocrown is manufactured in a dental …See details»
Dr. Jerome Chevalier - IAOCI
Born in 1970, Jérôme Chevalier is currently full Professor at the National Institute of Applied Sciences, in Lyon (INSA-Lyon), France.Jérôme Chevalier is mainly recognized for his work on …See details»
The Potential Role of Graphene in Developing the Next Generation …
Nov 29, 2016 Graphene is the first 2-dimensional material and possesses a plethora of original properties. Graphene and its derivatives have exhibited a great potential in a number of fields, …See details»
Chivalry & Sorcery - Wikipedia
Chivalry & Sorcery is a fantasy role-playing game (FRP) first published in 1977 by Fantasy Games Unlimited.Created by Edward E. Simbalist and Wilf K. Backhaus in 1977, Chivalry & …See details»
The Potential Role of Graphene in Developing the Next Generation …
Nov 29, 2016 1. Introduction. Material specifications and techniques are critical for the evolution of endovascular surgery. Graphene is a two-dimensional carbon allotrope comprised of sp 2 …See details»
Self-organization of the hematopoietic vascular niche and …
Dec 5, 2024 Here, we present a bioengineering approach to emulate the human bone marrow in vitro. Our developmentally inspired method uses self-organization of human hematopoietic …See details»